针对性化水晶甲胺和GHB使用的同行领导的chemsex干预措施的实施和形成性评估:M3THOD研究
Jack Freestone1,2, Daniel Storer3,4, Krista J Siefried5,6,7
1The Kirby Institute, University of New South Wales, Sydney, Australia. j.freestone@unsw.edu.au.
Harm reduction journal
|November 11, 2025
概括
这项研究评估了M3THOD,这是一项针对同性恋,双性恋和其他与男性发生性关系的男性 (GBMSM) 进行化学性行为的同行主导干预. 干预是可以接受的,适当的,可行的,为独特的需求提供有价值的支持.
科学领域:
- 公共卫生 公共卫生
- 行为科学 行为科学
- 成 药物 药物 药物 药物
背景情况:
- 参与chemsex的同性恋,双性恋和其他与男性发生性关系的男性 (GBMSM) 面临着获得医疗服务的障碍.
- 同行主导的干预措施在降低这些障碍和提供治疗支持方面表现有前途.
- 对于这样的同行领导的化学性行为干预,几乎没有正式的评估.
研究的目的:
- 评估M3THOD的可接受性,适当性和可行性,这是一种新的化学性交同行主导干预.
- 评估M3THOD在帮助个人减少与chemsex相关的伤害和获得专业服务方面的有效性.
主要方法:
- 使用定性方法进行了形成性评估.
- 数据是通过同行现场笔记和33个半结构化的深度访谈与客户,社区成员,同行工作者,经理和临床医生收集的.
- 用专题框架分析来分析收集的数据.
主要成果:
- 所有利益相关者都认为M3THOD是可以接受和适当的,需要对同行工作者提供结构化的灵活性.
- 参与者希望获得持续的同行支持,强调对水晶甲基胺的依赖.
- 可行性取决于对同行工作者的强有力的支持 (培训,监督,牧师照顾) 和强大的临床合作伙伴关系.
结论:
- M3THOD因其独特的支持而受到参与者的重视,传统服务无法满足这一需求.
- 同行工作者的实践经验促进了关系,验证和羞耻的缓解.
- 当有足够的资源支持同行工作者通过培训,监督和临床合作伙伴关系时,干预是可以接受的,适当的和可行的.
更多相关视频
08:53Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
Published on: May 31, 2019
5.5K
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
10.1K
相关概念视频
Community Based Intervention
264
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
264
Drug Control Governance: Regulatory Bodies and Their Impact
473
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
473
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
